glp 1 long term safety The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review As GLP-1 Use Expands, Long-Term

GLP-1RA Breast Cancer Survival Background BC is the most common cancer among females in the United States (US), and pre-existing conditions like type 2 diabetes (T2D) and obesity elevate the risk of reduced survival, disease progression, and recurrence

The difficulty of maintaining adherence to weekly injections can lead to treatment fatigue and weight regain, frustrating both patients and providers

This legal mandate ensures that compounding is reserved for situations where an identified individual patient has a unique medical need that cannot be met by a commercially available, FDA-approved drug

Endocrinology 140: 1132-1140, 1999

For thrivers, however, studies suggest that GLP-1s do not pose any risk beyond those that have already been identified in the general population

Beginner Tip: Start with shorter holds (e.g., 20-30 seconds) or perform on knees